• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌与炎症性肠病

Clostridium difficile and inflammatory bowel disease.

作者信息

Ananthakrishnan Ashwin N, Issa Mazen, Binion David G

机构信息

Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, USA.

出版信息

Med Clin North Am. 2010 Jan;94(1):135-53. doi: 10.1016/j.mcna.2009.08.013.

DOI:10.1016/j.mcna.2009.08.013
PMID:19944802
Abstract

The past decade has seen an alarming increase in the burden of disease associated with Clostridium difficile. Several studies have now demonstrated an increasing incidence of C difficile infection in patients with inflammatory bowel disease (IBD) with a more severe course of disease compared with the non-IBD population. This article summarizes the available literature on the impact of C difficile infection on IBD and discusses the various diagnostic testing and treatment options available. Also reviewed are clinical situations specific to patients with IBD that are important for the treating physician to recognize.

摘要

在过去十年中,与艰难梭菌相关的疾病负担出现了惊人的增长。现在有几项研究表明,炎症性肠病(IBD)患者中艰难梭菌感染的发病率不断上升,与非IBD人群相比,其病程更为严重。本文总结了关于艰难梭菌感染对IBD影响的现有文献,并讨论了各种可用的诊断测试和治疗选择。还回顾了IBD患者特有的临床情况,这些情况对于治疗医生来说很重要,需要加以识别。

相似文献

1
Clostridium difficile and inflammatory bowel disease.艰难梭菌与炎症性肠病
Med Clin North Am. 2010 Jan;94(1):135-53. doi: 10.1016/j.mcna.2009.08.013.
2
Clostridium difficile and inflammatory bowel disease.艰难梭菌与炎症性肠病。
Gastroenterol Clin North Am. 2009 Dec;38(4):711-28. doi: 10.1016/j.gtc.2009.07.003.
3
Impact of Clostridium difficile infection on pediatric inflammatory bowel disease.艰难梭菌感染对小儿炎症性肠病的影响。
J Pediatr. 2009 Jun;154(6):854-8. doi: 10.1016/j.jpeds.2008.12.039. Epub 2009 Feb 23.
4
Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD?非甾体抗炎药、抗生素、感染或压力会引发炎症性肠病发作吗?
Am J Gastroenterol. 2009 May;104(5):1298-313; quiz 1314. doi: 10.1038/ajg.2009.15. Epub 2009 Mar 31.
5
Treatment of Clostridium difficile-associated disease.艰难梭菌相关性疾病的治疗
Gastroenterology. 2009 May;136(6):1899-912. doi: 10.1053/j.gastro.2008.12.070. Epub 2009 May 7.
6
Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD.小儿炎症性肠病:凸显炎症性肠病的儿科差异
Med Clin North Am. 2010 Jan;94(1):35-52. doi: 10.1016/j.mcna.2009.10.002.
7
Cutaneous manifestations of inflammatory bowel disease.炎症性肠病的皮肤表现
Saudi J Gastroenterol. 2007 Oct-Dec;13(4):159-62. doi: 10.4103/1319-3767.36744.
8
Established and potential risk factors for Clostridum difficile infection.艰难梭菌感染的既定风险因素和潜在风险因素。
Indian J Med Microbiol. 2009 Oct-Dec;27(4):289-300. doi: 10.4103/0255-0857.55436.
9
Clostridium difficile-related death rates in Texas 1999-2005.1999 - 2005年德克萨斯州艰难梭菌相关死亡率
J Infect. 2009 Nov;59(5):303-7. doi: 10.1016/j.jinf.2009.08.019. Epub 2009 Sep 6.
10
Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital.一家三级护理医院10年间艰难梭菌的分子流行病学研究。
Clin Infect Dis. 2009 Oct 15;49(8):1141-7. doi: 10.1086/605638.

引用本文的文献

1
Microbiome analysis reveals the potential mechanism of herbal sitz bath complementary therapy in accelerating postoperative recovery from perianal abscesses.微生物组分析揭示了中药坐浴辅助疗法加速肛周脓肿术后恢复的潜在机制。
IET Syst Biol. 2025 Jan-Dec;19(1):e12114. doi: 10.1049/syb2.12114.
2
Management of Severe Colitis and Toxic Megacolon.重症结肠炎和中毒性巨结肠的管理
Clin Colon Rectal Surg. 2023 Dec 29;37(6):404-410. doi: 10.1055/s-0043-1777665. eCollection 2024 Nov.
3
The Effect of Mushroom Dietary Fiber on the Gut Microbiota and Related Health Benefits: A Review.
蘑菇膳食纤维对肠道微生物群的影响及相关健康益处:综述
J Fungi (Basel). 2023 Oct 19;9(10):1028. doi: 10.3390/jof9101028.
4
The prevalence and clinical characteristics of Clostridium difficile infection in Saudi patients admitted with inflammatory bowel disease: A case-control study.沙特住院炎症性肠病患者艰难梭菌感染的流行率和临床特征:病例对照研究。
Saudi J Gastroenterol. 2023 Jul-Aug;29(4):251-255. doi: 10.4103/sjg.sjg_476_22.
5
The Current Knowledge on Infection in Patients with Inflammatory Bowel Diseases.关于炎症性肠病患者感染的当前知识
Pathogens. 2022 Jul 21;11(7):819. doi: 10.3390/pathogens11070819.
6
Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program.在溃疡性结肠炎项目中接受托法替尼治疗的溃疡性结肠炎患者中的艰难梭菌感染。
Inflamm Bowel Dis. 2023 May 2;29(5):744-751. doi: 10.1093/ibd/izac139.
7
Characteristics of patients infected with Clostridioides difficile at a Saudi Tertiary Academic Medical Center and assessment of antibiotic duration.沙特一家三级学术医疗中心艰难梭菌感染患者的特征及抗生素使用时长评估
Gut Pathog. 2021 Feb 17;13(1):10. doi: 10.1186/s13099-021-00405-9.
8
An organized approach to imaging of benign cecal pathologies.一种针对盲肠良性病变的有组织的成像方法。
BJR Open. 2020 Jan 10;2(1):20190043. doi: 10.1259/bjro.20190043. eCollection 2020.
9
Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis.在需要住院治疗的炎症性肠病加重期联合使用抗生素和皮质类固醇:一项回顾性队列研究和荟萃分析。
Aliment Pharmacol Ther. 2016 Jan;43(1):52-60. doi: 10.1111/apt.13454. Epub 2015 Nov 5.
10
The impact of Clostridum difficile on surgical rate among ulcerative colitis patients: A systemic review and meta-analysis.艰难梭菌对溃疡性结肠炎患者手术率的影响:一项系统评价和荟萃分析。
Saudi J Gastroenterol. 2015 Jul-Aug;21(4):208-12. doi: 10.4103/1319-3767.161644.